Milde-Langosch K - Search Results

1

Role of HYAL1 expression in primary breast cancer in the formation of brain metastases.

Witzel I, Marx AK, Müller V, Wikman H, Matschke J, Schumacher U, Stürken C, Prehm P, Laakmann E, Schmalfeldt B, Milde-Langosch K, Oliveira-Ferrer L. Witzel I, et al. Breast Cancer Res Treat. 2017 Apr;162(3):427-438. doi: 10.1007/s10549-017-4135-6. Epub 2017 Feb 6. Breast Cancer Res Treat. 2017. PMID: 28168629

2

Expression pattern of the AP-1 family in breast cancer: association of fosB expression with a well-differentiated, receptor-positive tumor phenotype.

Bamberger AM, Methner C, Lisboa BW, Städtler C, Schulte HM, Löning T, Milde-Langosch K. Bamberger AM, et al. Int J Cancer. 1999 Oct 22;84(5):533-8. doi: 10.1002/(sici)1097-0215(19991022)84:5<533::aid-ijc16>3.0.co;2-j. Int J Cancer. 1999. PMID: 10502734

3

Expression of Rb2/p130 in breast and endometrial cancer: correlations with hormone receptor status.

Milde-Langosch K, Goemann C, Methner C, Rieck G, Bamberger AM, Löning T. Milde-Langosch K, et al. Br J Cancer. 2001 Aug 17;85(4):546-51. doi: 10.1054/bjoc.2001.1923. Br J Cancer. 2001. PMID: 11506494 Free PMC article.

4

Overexpression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype.

Milde-Langosch K, Bamberger AM, Rieck G, Kelp B, Löning T. Milde-Langosch K, et al. Breast Cancer Res Treat. 2001 May;67(1):61-70. doi: 10.1023/a:1010623308275. Breast Cancer Res Treat. 2001. PMID: 11518467

5

Expression pattern of the AP-1 family in endometrial cancer: correlations with cell cycle regulators.

Bamberger AM, Milde-Langosch K, Rössing E, Goemann C, Löning T. Bamberger AM, et al. J Cancer Res Clin Oncol. 2001 Sep;127(9):545-50. doi: 10.1007/s004320100255. J Cancer Res Clin Oncol. 2001. PMID: 11570575

6

FosB is highly expressed in normal mammary epithelia, but down-regulated in poorly differentiated breast carcinomas.

Milde-Langosch K, Kappes H, Riethdorf S, Löning T, Bamberger AM. Milde-Langosch K, et al. Breast Cancer Res Treat. 2003 Feb;77(3):265-75. doi: 10.1023/a:1021887100216. Breast Cancer Res Treat. 2003. PMID: 12602926

7

Expression of the CCAAT/enhancer-binding proteins C/EBPalpha, C/EBPbeta and C/EBPdelta in breast cancer: correlations with clinicopathologic parameters and cell-cycle regulatory proteins.

Milde-Langosch K, Löning T, Bamberger AM. Milde-Langosch K, et al. Breast Cancer Res Treat. 2003 May;79(2):175-85. doi: 10.1023/a:1023929504884. Breast Cancer Res Treat. 2003. PMID: 12825852

8

The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas.

Milde-Langosch K, Röder H, Andritzky B, Aslan B, Hemminger G, Brinkmann A, Bamberger CM, Löning T, Bamberger AM. Milde-Langosch K, et al. Breast Cancer Res Treat. 2004 Jul;86(2):139-52. doi: 10.1023/B:BREA.0000032982.49024.71. Breast Cancer Res Treat. 2004. PMID: 15319566

9

Expression and prognostic relevance of activated extracellular-regulated kinases (ERK1/2) in breast cancer.

Milde-Langosch K, Bamberger AM, Rieck G, Grund D, Hemminger G, Müller V, Löning T. Milde-Langosch K, et al. Br J Cancer. 2005 Jun 20;92(12):2206-15. doi: 10.1038/sj.bjc.6602655. Br J Cancer. 2005. PMID: 15928662 Free PMC article.

10

Role of Fra-2 in breast cancer: influence on tumor cell invasion and motility.

Milde-Langosch K, Janke S, Wagner I, Schröder C, Streichert T, Bamberger AM, Jänicke F, Löning T. Milde-Langosch K, et al. Breast Cancer Res Treat. 2008 Feb;107(3):337-47. doi: 10.1007/s10549-007-9559-y. Epub 2007 Mar 28. Breast Cancer Res Treat. 2008. PMID: 17393299

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters